
Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis
Author(s) -
Bhim Singh,
Heien,
Sangaralingham,
Schilz,
Kappelman,
Pankaj Shah,
Loftus
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/rt6w-ya24
Subject(s) - infliximab , ulcerative colitis , adalimumab , medicine , tumor necrosis factor alpha , disease